Opioid use and associated factors in 1676 patients with inflammatory bowel disease: a multicentre quality improvement project.
Samantha BaillieJimmy K LimdiAsh BassiAileen FraserGareth ParkesGlyn ScottTim RaineChristopher Andrew LambNicholas Alexander KennedyNatalia FumisMelissa A SmithAndrew NicolaouHolly EmmsJohn WyeAnouk LehmannIsabel CarberyJames GoodhandRobert LeesWaleed BeshyahPavit LuthraRichard PollokChristian SelingerPublished in: Frontline gastroenterology (2023)
1 in 10 patients with IBD attending outpatient appointments were opioid exposed in the past year while a quarter of inpatients were discharged with opioids, and 11% continued to use opioids 12 months after discharge. IBD services should aim to identify patients exposed to opioids, reduce exposure where possible and facilitate access to alternative pain management approaches.
Keyphrases
- pain management
- chronic pain
- quality improvement
- patients with inflammatory bowel disease
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- primary care
- peritoneal dialysis
- patient safety
- clinical trial
- mental health
- prognostic factors
- randomized controlled trial
- patient reported outcomes
- cross sectional
- tertiary care
- health insurance